Anticoagulant and antiplatelet therapy in patients with chronic kidney disease: risks versus benefits review. Curr Opin Nephrol Hypertens • June 3, 2014
Renal denervation in the management of resistant hypertension: current evidence and perspectives. Curr Opin Nephrol Hypertens • February 28, 2014
Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients? Curr Opin Nephrol Hypertens • January 12, 2009
Elevations in serum creatinine with RAAS blockade: why isn’t it a sign of kidney injury? Curr Opin Nephrol Hypertens • January 9, 2009
Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Curr Opin Nephrol Hypertens • January 9, 2009
Clinical significance and preventive strategies for contrast-induced nephropathy. Curr Opin Nephrol Hypertens • December 21, 2008
Triumph and tragedy: anemia management in chronic kidney disease. Curr Opin Nephrol Hypertens • December 21, 2008